UPDATE: Piper Sandler Starts Marker Therapeutics (MRKR) at Overweight, $6 PT
Tweet Send to a Friend
(Updated - March 25, 2021 8:30 AM EDT)
Piper Sandler analyst Joseph Catanzaro initiates coverage on Marker Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Joseph Catanzaro initiates coverage on Marker Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
